Boiron SA

BOI

Company Profile

  • Business description

    Boiron SA is a drug manufacturer that focuses on homeopathic products. The company's revenue is roughly split between its nonproprietary homeopathic medicines and products in its over-the-counter specialties category. Boiron's nonproprietary medicines are generic products that do not refer to any therapeutic indication, while the specialties category includes first-resort products provided in tablet form, are bottled to use as drops, syrups, or ointments. Geographical segments are France, Europe, North America, and other countries. It generates a majority of revenue from France. The company’s products include Oscillococcinum, Stodal and Stodaline, Arnigel, Camilia, Sedatif PC, Coryzalia, Homeoptic, and Homeovox.

  • Contact

    2, Avenue de l’Ouest Lyonnais No. 039
    Messimy69510
    FRA

    T: +33 478456100

    E: [email protected]

    http://www.boiron.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    2,771

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,880.6049.30-0.55%
CAC 408,099.4625.42-0.31%
DAX 4024,107.98121.93-0.50%
Dow JONES (US)48,374.5342.03-0.09%
FTSE 1009,671.9479.37-0.81%
HKSE25,235.41393.47-1.54%
NASDAQ23,113.4756.060.24%
Nikkei 22549,383.29784.82-1.56%
NZX 50 Index13,424.9516.810.13%
S&P 5006,816.120.39-0.01%
S&P/ASX 2008,598.9048.40-0.56%
SSE Composite Index3,824.8143.11-1.11%

Market Movers